Sutro Biopharma Inc.

NASDAQ: STRO · Real-Time Price · USD
0.83
-0.08 (-8.73%)
At close: Jun 05, 2025, 3:59 PM

Sutro Biopharma Statistics

Share Statistics

Sutro Biopharma has 84.46M shares outstanding. The number of shares has increased by 2.42% in one year.

84.46M
2.42%
1.6%
77.86%
n/a
55,486
2.96%

Short Selling Information

The latest short interest is 6.86M, so 8.12% of the outstanding shares have been sold short.

6.86M
8.12%
8.17%
4.39

Valuation Ratios

The PE ratio is -0.62 and the forward PE ratio is -0.91. Sutro Biopharma's PEG ratio is -0.01.

-0.62
-0.91
2.28
1
3.17
-0.73
-0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Sutro Biopharma.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.6, with a Debt / Equity ratio of 0.52.

2.6
2.6
0.52
-0.13
-0.12
-7.67

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$230,643.12
$-845,579.93
269
0.16
n/a

Taxes

2.36M
-1.05%

Stock Price Statistics

The stock price has increased by -77.93% in the last 52 weeks. The beta is 1.71, so Sutro Biopharma's price volatility has been higher than the market average.

1.71
-77.93%
0.81
2.27
44.53
1,876,692

Income Statement

In the last 12 months, Sutro Biopharma had revenue of 62.04M and earned -227.46M in profits. Earnings per share was -2.96.

62.04M
54.83M
-238.45M
-227.46M
-180.45M
-194.03M
-2.96
Full Income Statement

Balance Sheet

The company has 190.3M in cash and 23.15M in debt, giving a net cash position of 167.15M.

190.3M
23.15M
167.15M
-786.87M
321.43M
154.36M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -191.54M and capital expenditures -3.1M, giving a free cash flow of -194.64M.

-191.54M
-3.1M
-194.64M
-2.53
Full Cash Flow Statement

Margins

Gross margin is 88.37%, with operating and profit margins of -384.34% and -366.62%.

88.37%
-384.34%
-362.81%
-366.62%
-290.85%
-384.34%
-313.71%

Dividends & Yields

STRO does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for STRO is $6.5, which is 683.1% higher than the current price. The consensus rating is "Hold".

$6.5
683.1%
Hold
7
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-4.98
3